The Lancet: The antimicrobial crisis: enough advocacy, more action Editorial Board “…Addressing [antimicrobial resistance (AMR)] is a complex issue. The formal tripartite of WHO, the Food and Agriculture Organization, and the World Organisation for Animal Health must have a major role in identifying and promoting the implementation of feasible strategies…

Euractiv: Fighting antimicrobial resistance requires action on many fronts Koen Laenen, regulatory affairs and quality manager at Medicines for Europe, discusses antimicrobial resistance and the steps European entities and the AMR Industry Alliance are taking to address the issue (1/22).

BBC: Zimbabwe doctors end strike after billionaire’s offer (1/22). CIDRAP News: WHO calls antibiotic pipeline insufficient (Dall, 1/22). Devex: In Nigeria, there is no quick fix for antibiotic abuse (Adepoju, 1/23). The Guardian: Millions at risk after toxins found in Harare water supply, study finds (Chingono, 1/22). New York Times:…

The Guardian: Lack of antibiotics in low-income countries ‘worsening superbugs threat’ “Many antibiotics are unavailable in poorer countries despite higher infection rates, exacerbating the threat of drug-resistant superbugs, according to a report to be presented to world leaders and the bosses of top pharmaceutical companies in Davos. The report, released…

Washington Post: Fake drugs kill people and fund terror. African leaders hope to do something about it. “… ‘You are poor, and you are spending your money on something that is going to kill you,’ Faure Gnassingbé, the president of Togo, told the Washington Post in the country’s presidential palace.…

U.N. News: Urgent need for ‘immediate’ solutions to combat drug-resistant infections, warns WHO “Drug-resistant infections are on the rise as private investment in new antibiotic development declines, the World Health Organization (WHO) said on Friday. Two new WHO reports reveal that while some 50 new antibiotics and 10 biologics are…

Devex: Opinion: How to oppose the menace of antimicrobial resistance Serufusa Sekidde, board member of the AMR Industry Alliance “…5.7 million people, including 1 million children, are dying annually from antibiotic-treatable conditions because they cannot access the necessary antibiotics in time. … To increase access to antibiotics …, we need…

CIDRAP News: Industry urges more government action on antibiotic development “The level of funding for late-stage research and development of new antibiotics and other products to combat antimicrobial resistance (AMR) is insufficient to meet global health needs, and governments need to step up to the plate, according to an industry…

WHO: Lack of new antibiotics threatens global efforts to contain drug-resistant infections “Declining private investment and lack of innovation in the development of new antibiotics are undermining efforts to combat drug-resistant infections, says the World Health Organization (WHO). Two new reports reveal a weak pipeline for antibiotic agents. … The…

Devex: Opinion: Improving health outcomes in Papua New Guinea Amy Gildea, managing director of international development, Asia Pacific for Coffey (1/15). Devex: Opinion: Advances in AI and satellites can help us meet the SDGs Rhiannan Price, director of the sustainable development practice at Maxar (1/16). Forbes: Tokyo, 15 Others: Newest…